Ultralife (ULBI) EBITDA (2010 - 2026)

Ultralife's EBITDA history runs 17 years deep, the most recent figure standing at -$368000.0 for Q1 2026.

• In Q1 2026, EBITDA fell 116.91% year-over-year to -$368000.0; the TTM figure through Mar 2026 stood at -$7.6 million (down 238.19% YoY), while the FY2025 annual figure was -$5.0 million, down 184.36% from the prior year.
• EBITDA was -$368000.0 for Q1 2026 at Ultralife, up from -$7.5 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $3.4 million in Q4 2023 to a low of -$7.5 million in Q4 2025.
• Historically, EBITDA has averaged $331529.4 across 5 years, with a median of $868000.0 in 2022.
• The sharpest annual moves came in 2024 and 2025: EBITDA soared 1884.56% in 2024, then sank 930.91% in 2025.
• A 5-year view of EBITDA shows it stood at $868000.0 in 2022, then surged by 290.44% to $3.4 million in 2023, then tumbled by 121.48% to -$728000.0 in 2024, then tumbled by 930.91% to -$7.5 million in 2025, then surged by 95.1% to -$368000.0 in 2026.
• The last three EBITDA figures came in at -$368000.0 (Q1 2026), -$7.5 million (Q4 2025), and -$1.5 million (Q3 2025), per Business Quant data.